Navigating Your Tests and Biopsy
At a Glance
A nontoxic goiter is usually evaluated with TSH blood tests and a thyroid ultrasound. TI-RADS helps decide whether a nodule needs a needle biopsy, Bethesda results guide follow-up, and CT or MRI maps goiters extending into the chest.
The diagnostic process for a nontoxic goiter is designed to answer two main questions: how well is your thyroid working, and what is the physical nature of its enlargement? Most patients start with a physical exam and blood work, followed by detailed imaging and, if necessary, a specialized needle biopsy [1][2].
The Role of Blood Tests
The first step is checking your thyroid function. The primary tool for this is the TSH (thyroid-stimulating hormone) test [2][3].
- Normal TSH: This is the hallmark of a nontoxic goiter. It suggests that your thyroid is producing the correct amount of hormone despite being enlarged [2].
- Low TSH: This suggests your thyroid is overactive (hyperthyroidism). Your doctor will likely order Free T4 and Free T3 tests, and may order a radionuclide scan to see if a specific nodule is autonomously pumping out too much hormone [3].
- High TSH: This indicates an underactive thyroid (hypothyroidism), which is often seen in conditions like Hashimoto’s thyroiditis. This is a different state than the “euthyroid” (normal) state [1].
Thyroid Ultrasound and TI-RADS
A thyroid ultrasound uses sound waves to map your gland and evaluate your cervical (neck) lymph nodes [1]. Radiologists often use standardized systems like ACR TI-RADS (Thyroid Imaging Reporting and Data System) to grade the appearance of nodules [4][5].
TI-RADS assigns points based on five features: composition (solid or cystic), echogenicity (how bright it looks), shape, margins, and echogenic foci (tiny bright spots like microcalcifications) [4][5].
- TR1 or TR2: Very low risk; usually no biopsy needed.
- TR3: Low suspicion; biopsy usually considered if the nodule is 2.5 cm or larger.
- TR4: Moderate suspicion; biopsy usually considered if the nodule is 1.5 cm or larger.
- TR5: High suspicion; biopsy usually considered if the nodule is 1 cm or larger [4][5].
Note: These size thresholds are general guidelines. Your doctor will adjust the plan based on your personal risk factors (like prior radiation or family history), the appearance of your lymph nodes, and the specific guidelines they follow.
Fine Needle Aspiration (FNA) and the Bethesda System
If a nodule meets the criteria for further testing, your doctor may perform a Fine Needle Aspiration (FNA). A thin needle is used to take a small sample of cells [1]. A pathologist reviews these cells and assigns a Bethesda category, which indicates the approximate risk of cancer [6][7]:
| Bethesda Category | Description | Typical Next Steps |
|---|---|---|
| I | Nondiagnostic (Not enough cells) | Repeat biopsy or individualized follow-up [8] |
| II | Benign (Non-cancerous) | Clinical follow-up and periodic ultrasound [9] |
| III or IV | Indeterminate (Atypical/follicular) | May use molecular testing to refine risk, or diagnostic surgery [6][10] |
| V | Suspicious for Malignancy | High risk; usually requires surgery [7] |
| VI | Malignant | High risk; usually requires surgery [11] |
The exact risk percentages vary by the Bethesda edition being used and specific clinical factors. Molecular testing for Categories III/IV helps refine the risk, but it does not guarantee a benign or malignant outcome.
When Advanced Imaging (CT or MRI) is Needed
While ultrasound is excellent for looking at individual nodules, it cannot “see” through bone. If your goiter has retrosternal extension—meaning it has grown downward behind your collarbone or breastbone—an ultrasound will miss the bottom of the gland [12][13].
In these cases, a CT scan (computed tomography) or MRI is used to create a 3D view of your chest and neck [13][14]. This is critical if you have symptoms like difficulty breathing or swallowing, as it shows exactly how much the goiter is pressing on your trachea (windpipe) or esophagus [12][15]. If radioactive iodine is being considered as a treatment, discuss the use of iodinated CT contrast with your doctor, as the contrast can interfere with the therapy.
Empowering Your Care
You are the most important member of your care team. Always ask for a copy of your ultrasound report and your pathology report. Having these documents allows you to see the TI-RADS and Bethesda categories for yourself and ensures you have a complete record.
Common questions in this guide
What does a normal TSH mean if I have a nontoxic goiter?
How does TI-RADS affect whether a thyroid nodule needs a biopsy?
What do the Bethesda categories mean on a thyroid biopsy?
What happens if my TSH is low or high with a goiter?
When does a nontoxic goiter need a CT scan or MRI?
Why should I keep copies of my thyroid ultrasound and biopsy reports?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my ultrasound, what is the TI-RADS score for my largest or most suspicious nodules, and were my lymph nodes checked?
- 2.If my TSH is abnormal, what additional testing do we need to do to understand the cause?
- 3.Do any of my nodules meet the specific size and appearance thresholds for a fine needle aspiration (FNA) biopsy based on my clinical history?
- 4.If my biopsy comes back as 'indeterminate' (Bethesda III or IV), do you recommend molecular testing to clarify the risk?
- 5.Does my goiter extend below my collarbone (retrosternal), and if so, should we get a CT scan for better mapping?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Thyroid nodules: diagnosis and management.
Wong R, Farrell SG, Grossmann M
The Medical journal of Australia 2018; (209(2)):92-98 doi:10.5694/mja17.01204.
PMID: 29996756 - 2
Managing thyroid disease in general practice.
Walsh JP
The Medical journal of Australia 2016; (205(4)):179-84 doi:10.5694/mja16.00545.
PMID: 27510349 - 3
The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism.
Biondi B, Bartalena L, Cooper DS, et al.
European thyroid journal 2015; (4(3)):149-63 doi:10.1159/000438750.
PMID: 26558232 - 4
ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee.
Tessler FN, Middleton WD, Grant EG, et al.
Journal of the American College of Radiology : JACR 2017; (14(5)):587-595 doi:10.1016/j.jacr.2017.01.046.
PMID: 28372962 - 5
Visualizing thyroid health: a pictorial journey through 2017 ACR TI-RADS and common thyroid pathologies.
Dahal P, Parajuli S, Pradhan P
Annals of medicine and surgery (2012) 2024; (86(9)):5377-5388 doi:10.1097/MS9.0000000000002398.
PMID: 39239024 - 6
The 2023 Bethesda System for Reporting Thyroid Cytopathology.
Ali SZ, Baloch ZW, Cochand-Priollet B, et al.
Thyroid : official journal of the American Thyroid Association 2023; (33(9)):1039-1044 doi:10.1089/thy.2023.0141.
PMID: 37427847 - 7
The 2017 Bethesda System for Reporting Thyroid Cytopathology.
Cibas ES, Ali SZ
Journal of the American Society of Cytopathology 2017; (6(6)):217-222 doi:10.1016/j.jasc.2017.09.002.
PMID: 31043290 - 8
Fate of nondiagnostic thyroid fine needle aspirations.
Storozuk T, Biernacka A, Lastra R, et al.
Diagnostic cytopathology 2024; (52(12)):709-714 doi:10.1002/dc.25386.
PMID: 39051543 - 9
A Large Thyroid Fine Needle Aspiration Biopsy Cohort with Long-Term Population-Based Follow-Up.
Ng DL, van Zante A, Griffin A, et al.
Thyroid : official journal of the American Thyroid Association 2021; (31(7)):1086-1095 doi:10.1089/thy.2020.0689.
PMID: 33371796 - 10
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy.
Bellevicine C, Migliatico I, Sgariglia R, et al.
Cancer cytopathology 2020; (128(2)):107-118 doi:10.1002/cncy.22217.
PMID: 31821746 - 11
Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.
Higuchi M, Hirokawa M, Kanematsu R, et al.
Endocrine journal 2018; (65(12)):1193-1198 doi:10.1507/endocrj.EJ18-0290.
PMID: 30282887 - 12
An investigation into symptoms, diagnosis, treatment, and treatment complications in patients with retrosternal goiter.
Aghajanzadeh M, Asgary MR, Mohammadi F, et al.
Journal of family medicine and primary care 2018; (7(1)):224-229 doi:10.4103/jfmpc.jfmpc_286_17.
PMID: 29915764 - 13
Retrosternal Multinodular Goiter With Extensive Mediastinal Extension Requiring Combined Cervical Thyroidectomy and Median Sternotomy: A Case Report.
Charles JA, Vinoj SP, Vinoj SP, et al.
Cureus 2026; (18(5)):e108106 doi:10.7759/cureus.108106.
PMID: 42226874 - 14
Thyroidectomy Improves Tracheal Anatomy and Airflow in Patients with Nodular Goiter: A Prospective Cohort Study.
Sorensen JR, Lauridsen JF, Døssing H, et al.
European thyroid journal 2017; (6(6)):307-314 doi:10.1159/000480348.
PMID: 29234624 - 15
When Poverty Delays Care: The Silent Burden of Neglected Goiters in a World Where Basic Surgery Becomes a Luxury.
Najout H, Atmani W, Masad I, Bensghir M
Cureus 2025; (17(12)):e100212 doi:10.7759/cureus.100212.
PMID: 41602243
This page is for informational purposes only and does not constitute medical advice. Your clinician, radiologist, and pathologist should interpret your nontoxic goiter tests and biopsy results in the context of your health history.
Get notified when new evidence is published on nontoxic goiter.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.